We are live on ! Find out more
XERS icon

Xeris Biopharma Holdings
XERS

86 hedge funds and large institutions have $85M invested in Xeris Biopharma Holdings in 2020 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 35 increasing their positions, 14 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

190% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 10

150% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 14

86% more capital invested

Capital invested by funds: $45.8M → $85M (+$39.3M)

28% more funds holding

Funds holding: 67 → 86 (+19)

22.83% more ownership

Funds ownership: 62.51% → 85.34% (+23%)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $685K

Holders
86
Holders Change
+19
Holders Change %
+28.36%
% of All Funds
1.76%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
29
Increased
35
Reduced
14
Closed
10
Calls
–
Puts
$685K
Net Calls
-$685K
Net Calls Change
-$684K

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$9.22M
2
SM
Sabby Management
Florida
+$3.78M
3
Invesco
Invesco
Georgia
+$3.48M
4
SC
Sessa Capital
New York
+$3.27M
5
Millennium Management
Millennium Management
New York
+$1.76M

Top Sellers

Rank Fund Capital Flow
1
RG
Redmile Group
California
-$1.95M
2
HP
Hound Partners
New York
-$1.64M
3
Renaissance Technologies
Renaissance Technologies
New York
-$984K
4
DM
Deerfield Management
New York
-$887K
5
Blackstone Inc
Blackstone Inc
New York
-$762K
Name Holding Trade Value Shares
Change 		Change in
Stake
Legal & General Group
76
Legal & General Group
United Kingdom
$17K +$1.13K +324 +5%
Osaic Holdings
77
Osaic Holdings
Arizona
$9K +$12.4K +3,570 New
AIP
78
Ameritas Investment Partners
Nebraska
$8K +$4.93K +1,415 +84%
Bank of Montreal
79
Bank of Montreal
Ontario, Canada
$8K +$10.4K +3,000 New
BNP Paribas Financial Markets
80
BNP Paribas Financial Markets
France
$7.72K -$22K -6,330 -69%
Group One Trading
81
Group One Trading
Illinois
$6K +$5.92K +1,700 +354%
Simplex Trading
82
Simplex Trading
Illinois
$1K +$1.65K +473 New
JG
83
Jefferies Group
New York
$244 +$320K +91,800 New
Blackstone Inc
84
Blackstone Inc
New York
– -$762K -390,975 Closed
Fidelity Investments
85
Fidelity Investments
Massachusetts
– -$519K -266,300 Closed
Walleye Capital
86
Walleye Capital
New York
– -$221K -113,269 Closed
GCP
87
GSA Capital Partners
United Kingdom
– -$136K -69,800 Closed
Walleye Trading
88
Walleye Trading
New York
– -$85K -43,427 Closed
LCM
89
Laurion Capital Management
New York
– -$49K -25,000 Closed
AG
90
Algert Global
California
– -$23K -12,020 Closed
Victory Capital Management
91
Victory Capital Management
Texas
– -$22K -10,912 Closed
SIM
92
Spark Investment Management
New York
– -$20K -10,400 Closed
MAM
93
Meeder Asset Management
Ohio
– -$5K -2,346 Closed
BCA
94
Berman Capital Advisors
Georgia
– +$512 +147 New
1 2 3
4

XERS Hedge Fund Activity: Q2 2020 in Review

86 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Xeris Biopharma Holdings (XERS) for Q2 2020, worth a combined $85M — up 86% from $45.8M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new XERS positions and 10 closed out — a net gain of 19 holders — while 35 added to existing stakes and 14 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $9.22M. The largest seller was Redmile Group, cutting an estimated $1.95M.

  • 86 institutional investors held Xeris Biopharma Holdings (XERS) as of Q2 2020, up from 67 in Q1 2020.
  • Funds reported $85M of Xeris Biopharma Holdings stock for Q2 2020, up 86% quarter-over-quarter.
  • 29 funds opened new Xeris Biopharma Holdings positions in Q2 2020 and 10 closed out, a net change of +19 holders.
  • The largest Xeris Biopharma Holdings buyer in Q2 2020 was JP Morgan Chase, an estimated $9.22M added.
  • The largest Xeris Biopharma Holdings seller in Q2 2020 was Redmile Group, an estimated $1.95M sold.

Based on aggregated 13F filings for Q2 2020.